GLOBAL HEALTH

Mitigation of infectious diseases and malnutrition serves to enable more resilient and stable international communities culminating in reduction of global health burden and foreign conflict. I gained first-hand experience developing blood screening technologies domestically and subsequently translated those learnings to programs and interventions in Sub-Saharan Africa. My time in Malawi has forever left a mark on my heart and mind as it helped shape my world view.

Areas of Expertise
  • Global health and international development field efforts (Sub-Saharan Africa)
  • Molecular epidemiology, epidemic intelligence, environmental health, as well as, infectious disease and vector control
  • Epidemic responses: COVID-19 pandemic, Zika, dengue, malaria, tuberculosis, HIV, influenza, Chlamydia, and Gonorrhea

For over two decades, I have been advancing biotechnologies and gaining expertise on the frontlines of numerous medical, environmental, and public health interventions including:
  • Molecular testing for safety of the U.S. blood supply: HIV, HCV, West Nile virus (Gen-Probe > Grifols)
  • Launch of first combined Chlamydia and Gonorrhea APTIMA molecular tests, eliminating need for male genital swabbing using male/female urine specimens (Gen-Probe > Hologic)
  • Pioneering HIV CD4 mobile testing interventions in Sub-Saharan Africa to ensure efficacy of HIV anti-retroviral therapies (ART) in rural low resource settings (St. Gabriel's Hospital - Malawi)
  • Countermeasures for zoonotic and vector-borne infectious disease control domestically and internationally (Gen-Probe, St. Gabriel's Hospital - Malawi, Intrexon, Oxitec)